Literature DB >> 21994450

Characterization of the pleiotropic effects of the genotype G-specific 36-nucleotide insertion in the context of other hepatitis B virus genotypes.

Danielle Gutelius1, Jisu Li, Jack Wands, Shuping Tong.   

Abstract

The pregenomic RNA (pgRNA) of hepatitis B virus (HBV) serves as the messenger for both core and P proteins, with the downstream P gene translated by ribosomal leaky scanning. HBV replication begins with packaging of the pgRNA and P protein into core protein particles, followed by conversion of RNA into DNA. Genotype G has a low replication capacity due to a low pgRNA level. It has a 36-nucleotide (nt) insertion in the 5' end of the core gene, adding 12 residues to the core protein. The insertion is needed to maintain efficient core protein expression and genome replication but causes inefficient virion secretion yet high maturity of virion DNA. In the present study, we confirmed that the 36-nt insertion had similar effects on core protein expression and virion secretion when it was introduced into genotype A and D clones but no impact on virion genome maturity. Surprisingly, the insertion impaired genome replication in both genotypes. Transcomplementation assays suggest that increased efficiency of core protein translation diminishes ribosomal scanning toward the downstream P gene. Indeed, mutating the core gene Kozak sequence restored core protein to lower levels but increased replication of the insertion mutant. Similar mutations impaired replication in genotype G. On the other hand, replacement of the core promoter sequence of genotype G with genotype A sequence increased pgRNA transcription and genome replication, implicating this region in the low replication capacity of genotype G. Why the 36-nt insertion is present in genotype G but absent in other genotypes is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994450      PMCID: PMC3233120          DOI: 10.1128/JVI.05583-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen.

Authors:  T T Yuan; P C Tai; C Shih
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Hepatitis B virus core gene mutations which block nucleocapsid envelopment.

Authors:  M Koschel; D Oed; T Gerelsaikhan; R Thomssen; V Bruss
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

4.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

5.  Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation.

Authors:  Dirk Ponsel; Volker Bruss
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G.

Authors:  Hideaki Kato; Etsuro Orito; Robert G Gish; Natalie Bzowej; Margaret Newsom; Fuminaka Sugauchi; Seiji Suzuki; Ryuzo Ueda; Yuzo Miyakawa; Masashi Mizokami
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

7.  Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein.

Authors:  S Le Pogam; T T Yuan; G K Sahu; S Chatterjee; C Shih
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor.

Authors:  J Li; J H Ou
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Krüppel-like factor 15 activates hepatitis B virus gene expression and replication.

Authors:  Jie Zhou; Thomas Tan; Yongjun Tian; Bojian Zheng; J-H James Ou; Eric J Huang; T S Benedict Yen
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

10.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  5 in total

1.  Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.

Authors:  Li Zong; Yanli Qin; Haodi Jia; Lei Ye; Yongxiang Wang; Jiming Zhang; Jack R Wands; Shuping Tong; Jisu Li
Journal:  Virology       Date:  2017-03-03       Impact factor: 3.616

2.  Core gene insertion in hepatitis B virus genotype G functions at both the encoded amino acid sequence and RNA structure levels to stimulate core protein expression.

Authors:  Jing Zhang; Li Zong; Yongxiang Wang; Cheng Li; Chaoyang Chen; Yumei Wen; Jisu Li; Shuping Tong
Journal:  Virology       Date:  2018-11-08       Impact factor: 3.616

Review 3.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 4.  Hepatitis B Virus Genotype G: The Odd Cousin of the Family.

Authors:  Natalia M Araujo; Carla Osiowy
Journal:  Front Microbiol       Date:  2022-03-31       Impact factor: 5.640

5.  High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011.

Authors:  Antoinette C van der Kuyl; Fokla Zorgdrager; Boris Hogema; Margreet Bakker; Suzanne Jurriaans; Nicole K T Back; Ben Berkhout; Hans L Zaaijer; Marion Cornelissen
Journal:  BMC Infect Dis       Date:  2013-11-14       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.